| Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.080 | AlteredExpression | disease | BEFREE | Other cardiovascular complications seen in GBS patients were Increased pro-BNP(26.04%), raised troponin T levels(3.12%), acute coronary syndrome(2.08%), heart failure(2.08%) and abnormal 2D echo findings(8.33%). | 31504947 | 2020 | ||||
|
0.080 | Biomarker | disease | BEFREE | Cardiac biomarkers troponin and brain natriuretic peptide/N-terminal proBNP (BNP/NT-proBNP) have been extensively studied in heart failure and acute coronary syndromes. | 30701097 | 2018 | ||||
|
0.080 | Biomarker | disease | BEFREE | Because biomarker assessment is often the first diagnostic employed in such patients, understanding biomarker differences in men vs. women may improve female morbidity and mortality rates.Some key examples of cardiac biomarker utility based on sex include contemporary use of "unisex" troponin reference intervals under-diagnosing myocardial necrosis in women; greater use of hsCRP in the setting of acute coronary syndrome (ACS) could lead to better stratification in women; and greater use of BNP with sex-specific thresholds in ACS could also lead to more timely risk stratification in women.Accurate diagnosis, appropriate risk management, and monitoring are key in the prevention and treatment of cardiovascular diseases; however, the assessment tools used must also be useful or at least assessed for utility in both sexes. | 30223899 | 2018 | ||||
|
0.080 | Biomarker | disease | LHGDN | Osteoprotegerin and B-type natriuretic peptide in non-ST elevation acute coronary syndromes: relation to coronary artery narrowing and plaques number. | 18328262 | 2008 | ||||
|
0.080 | Biomarker | disease | LHGDN | Prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. | 16624649 | 2006 | ||||
|
0.080 | Biomarker | disease | LHGDN | Prognostic value of N-terminal-pro-brain natriuretic peptide measurements in patients with acute coronary syndromes. | 16733598 | 2006 | ||||
|
0.080 | Biomarker | disease | LHGDN | Dynamics in N-terminal pro-brain natriuretic peptide concentration in patients with non-ST-elevation acute coronary syndrome. | 16338268 | 2005 | ||||
|
0.080 | Biomarker | disease | LHGDN | Furthermore, BNP and NT-proBNP are predictors of morbidity and mortality in patients with heart failure, but also in acute coronary syndrome, myocardial infarction, pulmonary embolism and other cardiovascular diseases. | 15732251 | 2004 |